Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2009

01-08-2009 | Editorial

New data favouring that neurotrophins are of importance in arthritis

Author: Sture Forsgren

Published in: Arthritis Research & Therapy | Issue 4/2009

Login to get access

Abstract

Neurotrophins are important in inflammation. In an article in Arthritis Research & Therapy, Barthel and collaborators give new information on the existence of neurotrophin production in the synovial tissue of arthritic joints. These findings, together with other recent findings, stress that neurotrophins should be considered important factors in arthritis. This is reinforced by the facts that they are also produced by articular chondrocytes and that receptors for these are present in the synovial tissue and on chondrocytes. The importance of neurotrophins in joints should be further studied, including examinations on the efficacy of interfering with their effects in arthritis.
Literature
1.
go back to reference Barthel C, Yeremenko N, Jacobs R, Schmidt RE, Bernateck M, Zeidler H, Tak P-P, Baeten D, Rihl M: Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res Ther. 2009, 11: R82-10.1186/ar2716.PubMedCentralCrossRefPubMed Barthel C, Yeremenko N, Jacobs R, Schmidt RE, Bernateck M, Zeidler H, Tak P-P, Baeten D, Rihl M: Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res Ther. 2009, 11: R82-10.1186/ar2716.PubMedCentralCrossRefPubMed
2.
go back to reference Grimsholm O, Guo Y, Ny T, Forsgren S: Expression patterns of neurotrophins and neurotrophin receptors in the articular chondrocytes and the inflammatory infiltrates in knee joint arthritis. Cells Tissues Organs. 2008, 188: 299-309. 10.1159/000121432.CrossRefPubMed Grimsholm O, Guo Y, Ny T, Forsgren S: Expression patterns of neurotrophins and neurotrophin receptors in the articular chondrocytes and the inflammatory infiltrates in knee joint arthritis. Cells Tissues Organs. 2008, 188: 299-309. 10.1159/000121432.CrossRefPubMed
3.
go back to reference Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L: Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol. 2003, 21: 617-624.PubMed Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L: Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol. 2003, 21: 617-624.PubMed
4.
go back to reference Weidler C, Holzer C, Harbuz M, Hofbauer R, Angele P, Scholmerich J, Straub RH: Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis. 2005, 64: 13-20. 10.1136/ard.2003.016154.PubMedCentralCrossRefPubMed Weidler C, Holzer C, Harbuz M, Hofbauer R, Angele P, Scholmerich J, Straub RH: Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis. 2005, 64: 13-20. 10.1136/ard.2003.016154.PubMedCentralCrossRefPubMed
5.
go back to reference Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S: BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters. Clin Rheumatol. 2008, 27: 1289-1297. 10.1007/s10067-008-0910-4.CrossRefPubMed Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S: BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters. Clin Rheumatol. 2008, 27: 1289-1297. 10.1007/s10067-008-0910-4.CrossRefPubMed
6.
go back to reference Rihl M, Kruithof E, Barthel C, De Keyser F, Veys EM, Zeidler H, Yu DT, Kuipers JG, Baeten D: Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to therapy. Ann Rheum Dis. 2005, 64: 1542-1549. 10.1136/ard.2004.032599.PubMedCentralCrossRefPubMed Rihl M, Kruithof E, Barthel C, De Keyser F, Veys EM, Zeidler H, Yu DT, Kuipers JG, Baeten D: Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to therapy. Ann Rheum Dis. 2005, 64: 1542-1549. 10.1136/ard.2004.032599.PubMedCentralCrossRefPubMed
7.
go back to reference Raychaudhuri SP, Raychaudhuri SK: The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells. Scand J Rheumatol. 2009, 38: 207-215. 10.1080/03009740802448866.CrossRefPubMed Raychaudhuri SP, Raychaudhuri SK: The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells. Scand J Rheumatol. 2009, 38: 207-215. 10.1080/03009740802448866.CrossRefPubMed
8.
go back to reference Aloe L, Tirassa P, Lambiase A: The topical application of nerve growth factor as a pharmalogical tool for human corneal and skin ulcers. Pharmacol Res. 2008, 57: 253-258. 10.1016/j.phrs.2008.01.010.CrossRefPubMed Aloe L, Tirassa P, Lambiase A: The topical application of nerve growth factor as a pharmalogical tool for human corneal and skin ulcers. Pharmacol Res. 2008, 57: 253-258. 10.1016/j.phrs.2008.01.010.CrossRefPubMed
9.
go back to reference Mammoto T, Seerattan RA, Paulson KD, Leonard CA, Bray RC, Salo PT: Nerve growth factor improves ligament healing. J Orthop Res. 2008, 26: 957-964. 10.1002/jor.20615.CrossRefPubMed Mammoto T, Seerattan RA, Paulson KD, Leonard CA, Bray RC, Salo PT: Nerve growth factor improves ligament healing. J Orthop Res. 2008, 26: 957-964. 10.1002/jor.20615.CrossRefPubMed
10.
go back to reference del Porto F, Aloe L, Lagana B, Triaca V, Nofroni I, DÁmelio R: Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-α blockers. Ann NY Acad Sci. 2006, 1069: 438-443. 10.1196/annals.1351.042.CrossRefPubMed del Porto F, Aloe L, Lagana B, Triaca V, Nofroni I, DÁmelio R: Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-α blockers. Ann NY Acad Sci. 2006, 1069: 438-443. 10.1196/annals.1351.042.CrossRefPubMed
Metadata
Title
New data favouring that neurotrophins are of importance in arthritis
Author
Sture Forsgren
Publication date
01-08-2009
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2009
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2754

Other articles of this Issue 4/2009

Arthritis Research & Therapy 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine